Cambridge Investment Research Advisors’s Neuberger High Yield Strategies Fund Inc Rights (expiring April 15, 2026) NHS.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10,252
Closed 4226
2026
Q1
$0 Buy
+10,252
New +$89 ﹤0.01% 4120

Cambridge Investment Research Advisors's NHS.RT Position: Q2 2026 in Review

Cambridge Investment Research Advisors sold out of Neuberger High Yield Strategies Fund Inc Rights (expiring April 15, 2026) (NHS.RT) in Q2 2026, closing a stake of 10,252 shares.

Cambridge Investment Research Advisors first reported a position in NHS.RT in Q1 2026 and held it in 1 quarter. The position peaked at $0 in Q1 2026. 0 funds tracked by Wall St. Rank hold NHS.RT as of Q2 2026.

  • Cambridge Investment Research Advisors reported no remaining Neuberger High Yield Strategies Fund Inc Rights (expiring April 15, 2026) position as of Q2 2026 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 10,252 Neuberger High Yield Strategies Fund Inc Rights (expiring April 15, 2026) shares in Q2 2026.
  • Cambridge Investment Research Advisors first reported a position in Neuberger High Yield Strategies Fund Inc Rights (expiring April 15, 2026) in Q1 2026 and held it in 1 quarter.
  • Cambridge Investment Research Advisors's Neuberger High Yield Strategies Fund Inc Rights (expiring April 15, 2026) position peaked at $0 in Q1 2026.
  • 0 funds tracked by Wall St. Rank held Neuberger High Yield Strategies Fund Inc Rights (expiring April 15, 2026) as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.